Al-Tamimi J, Alomar S, Aljuaimlani A, Mansour L
Innate Immun. 2025; 31:17534259251314774.
PMID: 39828905
PMC: 11774482.
DOI: 10.1177/17534259251314774.
Qiao W, Dong P, Chen H, Zhang J
Cells. 2024; 13(23.
PMID: 39682724
PMC: 11640743.
DOI: 10.3390/cells13231976.
Baumgartner C, Ebrahimi-Nik H, Iracheta-Vellve A, Hamel K, Olander K, Davis T
Nature. 2023; 622(7984):850-862.
PMID: 37794185
PMC: 10599993.
DOI: 10.1038/s41586-023-06575-7.
Chen X, Jiang L, Liu X
Front Immunol. 2022; 13:954804.
PMID: 35967421
PMC: 9364606.
DOI: 10.3389/fimmu.2022.954804.
Medjouel Khlifi H, Guia S, Vivier E, Narni-Mancinelli E
Front Immunol. 2022; 13:898745.
PMID: 35757695
PMC: 9231431.
DOI: 10.3389/fimmu.2022.898745.
The changing role of natural killer cells in cancer metastasis.
Chan I, Ewald A
J Clin Invest. 2022; 132(6).
PMID: 35289318
PMC: 8920322.
DOI: 10.1172/JCI143762.
iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting.
Goldenson B, Hor P, Kaufman D
Front Immunol. 2022; 13:841107.
PMID: 35185932
PMC: 8851389.
DOI: 10.3389/fimmu.2022.841107.
Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives.
Jacquelot N, Seillet C, Souza-Fonseca-Guimaraes F, Sacher A, Belz G, Ohashi P
Int J Mol Sci. 2021; 22(16).
PMID: 34445750
PMC: 8396475.
DOI: 10.3390/ijms22169044.
Lectin-like transcript 1 as a natural killer cell-mediated immunotherapeutic target for triple negative breast cancer and prostate cancer.
Sun Y, Malaer J, Mathew P
J Cancer Metastasis Treat. 2021; 2019(5).
PMID: 34322598
PMC: 8315106.
DOI: 10.20517/2394-4722.2019.29.
MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It.
Shklovskaya E, Rizos H
Int J Mol Sci. 2021; 22(13).
PMID: 34201655
PMC: 8268865.
DOI: 10.3390/ijms22136741.
Neoadjuvant immunotherapy in resectable head and neck cancer: oral cavity carcinoma as a potential research model.
Gutierrez Calderon V, Cantero Gonzalez A, Galvez Carvajal L, Aguilar Lizarralde Y, Dominguez A
Ther Adv Med Oncol. 2021; 13:1758835920984061.
PMID: 33747147
PMC: 7905482.
DOI: 10.1177/1758835920984061.
Comparison of responsiveness to cancer development and anti-cancer drug in three different C57BL/6N stocks.
Kang M, Kim J, Park J, Choi H, Bae S, Kim K
Lab Anim Res. 2020; 35:17.
PMID: 32257905
PMC: 7081605.
DOI: 10.1186/s42826-019-0015-z.
Killer Cell Immunoglobulin-Like Receptors (KIRs) Genotype and Haplotype Analysis in Iranians with Non-Melanoma Skin Cancers.
Yousefinejad F, Jowkar F, Barani S, Jamali E, Mahmoudi E, Ramezani A
Iran Biomed J. 2019; 23(5):330-7.
PMID: 31103021
PMC: 6661125.
Targeting natural killer cells in solid tumors.
Habif G, Crinier A, Andre P, Vivier E, Narni-Mancinelli E
Cell Mol Immunol. 2019; 16(5):415-422.
PMID: 30911118
PMC: 6474204.
DOI: 10.1038/s41423-019-0224-2.
The tumour microenvironment and immune milieu of cholangiocarcinoma.
Fabris L, Perugorria M, Mertens J, Bjorkstrom N, Cramer T, Lleo A
Liver Int. 2019; 39 Suppl 1:63-78.
PMID: 30907492
PMC: 10878127.
DOI: 10.1111/liv.14098.
Immune regulation and anti-cancer activity by lipid inflammatory mediators.
Khadge S, Sharp J, McGuire T, Thiele G, Black P, DiRusso C
Int Immunopharmacol. 2018; 65:580-592.
PMID: 30447537
PMC: 6322683.
DOI: 10.1016/j.intimp.2018.10.026.
A -derived polypeptide promotes activation of NK cells for antitumor therapy.
Ortiz A, Lenz L
Immunohorizons. 2018; 1(4):53-62.
PMID: 29658011
PMC: 5895080.
DOI: 10.4049/immunohorizons.1700013.
Comparison of humoral and cell-mediated immunity in three different C57BL/6N mouse substrains.
Kim H, Choi J, Kim K, Jung Y, Cho J, Hwang D
Lab Anim Res. 2017; 33(2):132-139.
PMID: 28747979
PMC: 5527139.
DOI: 10.5625/lar.2017.33.2.132.
Comparative study of the immunological characteristics of three different C57BL/6N mouse substrains.
Choi J, Kim H, Kim K, Jung Y, Cho J, Hwang D
Lab Anim Res. 2017; 33(2):124-131.
PMID: 28747978
PMC: 5527138.
DOI: 10.5625/lar.2017.33.2.124.
Use of C57BL/6N mice on the variety of immunological researches.
Song H, Hwang D
Lab Anim Res. 2017; 33(2):119-123.
PMID: 28747977
PMC: 5527137.
DOI: 10.5625/lar.2017.33.2.119.